Otsuka and Click Therapeutics’ Rejoyn has become the first prescription digital therapeutic (DTx) to be approved by the FDA for people with major depressive disorder. Rejoyn (formerly CT-152), a ...

An FDA-approved digital therapeutic (DTx) that can be used to help people living with major depressive disorder (MDD) has been launched in the US and is available in mobile app stores. Otsuka ...

The narrowing gap between decentralized and traditional finance is groundbreaking and leading this movement is DTX Exchange (DTX). This innovative trading platform combines key elements of CEX and DEX ...

DTX Exchange is redefining crypto trading with its dual-chain infrastructure, bridging traditional finance and DeFi. As one of the most anticipated platforms, DTX Exchange has already raised over ...

The crypto market buzz has intensified after DTX Exchange (DTX) saw an incredible 700% presale pump. This increase has many speculating that DTX is the top ICO of the year. Moreover, interest is also ...

DTX Exchange is gaining serious momentum, and its latest presale numbers prove it. Since the announcement of the presale, the exchange has raised over $14 million with more investors flooding in. Soon ...

DTX Exchange is capturing investor attention as one of the best presale opportunities in 2025. The hybrid trading platform is revolutionizing DeFi by offering access to 120,000 financial instruments, ...

With the Cardano price striving to break through key resistance levels and DTX Exchange making waves with its groundbreaking hybrid trading platform, crypto investors are eagerly watching these two ...

Often regarded as leading crypto coins, Solana (SOL) and Ripple (XRP) show dependability and steady rise. But a new rival, DTX Exchange (DTX), is causing waves with its exponential development ...

In the current market scenario, many experts are picking DTX Exchange as a good addition to portfolios with its strong fundamentals and high-return presale performance. Some describe DTX Exchange’s ...